FDA Inspection
NOVA Biologics, Inc.NOVA Biologics, Inc. – FDA Inspection, Sep 16, 2026
Record Details
This FDA Inspection record concerns NOVA Biologics, Inc., with an inspection on September 16, 2026, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 6d106ac2-31f6-4f0e-8204-5ce2740d1a4a
Inspection Facts
- Inspection number
- 1287240
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 606.121(c)(10)Caution statement - manufacturing use
- 21 CFR 606.121(c)(11)Required labeling information - manufacturing use
- 21 CFR 606.121(c)(2)Name, address, unique facility identifier
- 21 CFR 606.121(c)(4)(i)Expiration date
- 21 CFR 610.40(c)(2)Device component - labeling
- 21 CFR 610.40(h)(2)(ii)Labeling of reactive units, units from deferred donors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NOVA Biologics, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 27, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for NOVA Biologics, Inc.
- FDA Inspection 1067663 - 2018-09-19
- FDA Inspection 788291 - 2012-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.